Salarius Pharmaceuticals Inc (NASDAQ: SLRX): Stock Forecast For 2024 Sees A A Decline Of -66.72%
In today’s recent session, 3.26 million shares of the Salarius Pharmaceuticals Inc (NASDAQ:SLRX) have been traded, and its beta is 1.02. Most recently the company’s